News
01-30-2012, 09:30 AM
Applied Spectral Imaging (ASI) announced today that ASI's GenASIs Scan & Analysis, SpotScan used for the detection of chromosomal aberrations in bladder cancer has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.
More... (http://www.news-medical.net/news/20120130/ASIs-GenASIs-for-detection-of-chromosomal-aberrations-in-bladder-cancer-receives-FDA-approval.aspx)
More... (http://www.news-medical.net/news/20120130/ASIs-GenASIs-for-detection-of-chromosomal-aberrations-in-bladder-cancer-receives-FDA-approval.aspx)